ADLENS GROUP LIMITED

Active Eynsham

Activities of head offices

10 employees website.com
Life sciences and medical technology Activities of head offices
A

ADLENS GROUP LIMITED

Activities of head offices

Founded 14 Jan 2008 Active Eynsham, United Kingdom 10 employees website.com
Life sciences and medical technology Activities of head offices
Accounts Submitted 5 Jun 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 25 Feb 2026 Next due 28 Jan 2027 8 months remaining
Net assets £-136M £14M 2024 year on year
Total assets £1M £93K 2024 year on year
Total Liabilities £137M £14M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Chilbrook House 1 Oasis Park Stanton Harcourt Road Eynsham Oxfordshire OX29 4TP United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ADLENS GROUP LIMITED (06472076), an active life sciences and medical technology company based in Eynsham, United Kingdom. Incorporated 14 Jan 2008. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£351.94k

Increased by £58.48k (+20%)

Net Assets

-£135.86M

Decreased by £14.11M (-12%)

Total Liabilities

£136.92M

Increased by £14.20M (+12%)

Turnover

N/A

Employees

10

Decreased by 1 (-9%)

Debt Ratio

12934%

Increased by 230 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 24,116 Shares £3.97m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
14 Jan 202611,349£1.87m£1.87m
2 Dec 202512,767£2.10m£164.61

Officers

Officers

3 active
Status
Bignone, Julie AnnSecretaryUnknownUnknown9 Dec 2025Active
Loesel, Frieder Hans, DrDirectorGermanGermany581 Jan 2026Active
Ng, SandyDirectorSingaporeanSingapore4710 Jan 2026Active

Shareholders

Shareholders (2)

Onprime Developments Limited
96.6%
103,694
Sunnyside Up Investments Limited
3.4%
3,648

Persons with Significant Control

Persons with Significant Control (1)

1 Active

James Yue Jia Chen

British

Active
Notified 3 May 2016
Residence Hong Kong, China
DOB July 1961
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

ADLENS GROUP LIMITED Current Company
ADLENS LTD united kingdom
ADLENS IPR LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 May 2026OfficersAppointment of Mr Paul Anthony Tomasic as director on 1 May 2026
28 Apr 2026CapitalAllotment of shares (GBP 1,164.46) on 27 Apr 2026
25 Feb 2026Confirmation StatementConfirmation statement made on 14 Jan 2026 with updates
19 Jan 2026OfficersAppointment of Ms Sandy Ng as director on 10 Jan 2026
14 Jan 2026OfficersAppointment of Dr Robert Edward Stevens as director on 1 Jan 2026
5 May 2026 Officers

Appointment of Mr Paul Anthony Tomasic as director on 1 May 2026

28 Apr 2026 Capital

Allotment of shares (GBP 1,164.46) on 27 Apr 2026

25 Feb 2026 Confirmation Statement

Confirmation statement made on 14 Jan 2026 with updates

19 Jan 2026 Officers

Appointment of Ms Sandy Ng as director on 10 Jan 2026

14 Jan 2026 Officers

Appointment of Dr Robert Edward Stevens as director on 1 Jan 2026

Recent Activity

Latest Activity

Appointment of Mr Paul Anthony Tomasic as director on 1 May 2026

2 weeks ago on 5 May 2026

Allotment of shares (GBP 1,164.46) on 27 Apr 2026

3 weeks ago on 28 Apr 2026

Confirmation statement made on 14 Jan 2026 with updates

2 months ago on 25 Feb 2026

Appointment of Ms Sandy Ng as director on 10 Jan 2026

4 months ago on 19 Jan 2026

Appointment of Dr Robert Edward Stevens as director on 1 Jan 2026

4 months ago on 14 Jan 2026